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Ataxia-telangiectasia mutated (ATM)–deficient lymphocytes exhibit defects in coding joint
formation during V(D)J recombination in vitro. Similar defects in vivo should affect both
T and B cell development, yet the lymphoid phenotypes of ATM deficiency are more pronounced in the T cell compartment. In this regard, ATM-deficient mice exhibit a preferential
T lymphopenia and have an increased incidence of nontransformed and transformed T cells
with T cell receptor 𝛂/𝛅 locus translocations. We demonstrate that there is an increase in
the accumulation of unrepaired coding ends during different steps of antigen receptor gene
assembly at both the immunoglobulin and T cell receptor loci in developing ATM-deficient
B and T lymphocytes. Furthermore, we show that the frequency of ATM-deficient 𝛂𝛃 T cells
with translocations involving the T cell receptor 𝛂/𝛅 locus is directly related to the number
of T cell receptor 𝛂 rearrangements that these cells can make during development. Collectively, these findings demonstrate that ATM deficiency leads to broad defects in coding
joint formation in developing B and T lymphocytes in vivo, and they provide a potential
molecular explanation as to why the developmental impact of these defects could be more
pronounced in the T cell compartment.
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Abbreviations used: AMuLV
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mutated; BCR, B cell receptor;
CE, coding end; DN, double
negative; DP, double positive;
DSB, double-strand break;
JNK, c-Jun N-terminal kinase;
LMPCR, ligation-mediated
PCR; P8, probe 8; PR2,
RAG-2 probe; PS6, SJA
probe 6; RS, recombination
signal; SE, signal end; WCP,
whole chromosome paint.

The exons encoding the variable region of lymphocyte antigen receptor chains are assembled
from V, J, and in some cases D gene segments
through the process of V(D)J recombination (1).
The V(D)J recombination reaction is initiated by the RAG-1 and -2 proteins (hereafter
referred to as RAG). After synaptic complex
formation, RAG introduces DNA double-strand
breaks (DSBs) at the border of recombining
gene segments and their flanking recombination signals (RSs) (2–4). The resulting pairs of
blunt phosphorylated signal ends (SEs) and
hairpin-sealed coding ends (CEs) are processed
and joined into a signal joint and coding joint,
respectively, by proteins of the nonhomologous end-joining pathway of DNA DSB
repair (5).
The ataxia-telangiectasia (A-T) mutated
(ATM) protein is a serine/threonine kinase activated early in the response to DNA DSBs (6–9).
The online version of this article contains supplemental material.
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Mutations in the ATM gene cause A-T, a disease with lymphoid phenotypes that include
lymphopenia and a predisposition to lymphoid
malignancies (10, 11). Most lymphoid malignancies in A-T patients have karyotypic abnormalities with chromosome breakpoints clustering
near antigen receptor genes (11). In addition,
10% of nontransformed T cells from A-T
patients have translocations or large inversions
involving chromosomes containing TCR genes
(chromosomes 7 and 14) (11).
Like A-T patients, ATM-deficient mice are
lymphopenic, and they almost invariably die
from thymic lymphomas with translocations
involving the TCRα/δ locus by 3–6 mo of age
(12–16). Thymocytes from ATM-deficient
mice have an increased frequency of biallelic
loss of distal Vα gene segments, and 11% of nontransformed αβ T cells in these mice have karyotypic abnormalities involving chromosome 14,
which contains the TCRα/δ locus (17, 18).
In ATM-deficient mice, the thymic lymphomas
1371

with TCRα/δ locus translocations are RAG dependent, and
the T lymphopenia is partially rescued by TCR transgene
expression (19–21). Collectively, these findings suggest that
ATM functions during antigen receptor gene assembly.
RAG-induced DSBs are generated exclusively in developing lymphocytes at the G1 phase of the cell cycle (22, 23).
ATM enforces the G1-S cell-cycle checkpoint through phosphorylation and stabilization of p53 and activation of the
Chk2 kinase (7–9). Furthermore, p53 promotes apoptosis of
cells with persistent unrepaired DSBs (7–9). In developing
lymphocytes, ATM could therefore function primarily by
activating the G1-S cell-cycle checkpoint in response to RAGinduced DSBs. However, mice deficient in either p53 or
Chk2 are not lymphopenic and are not prone to lymphoid
tumors with antigen receptor gene translocations, as are
ATM-deficient mice (24, 25). Thus, ATM likely has distinct
functions, in addition to its cell-cycle checkpoint/apoptotic
activities, during V(D)J recombination.
Analyses of ATM-deficient cell lines did not reveal
defects in V(D)J recombination of extrachromosomal plasmid
substrates (26). However, ATM has been found to associate
with RAG-induced DSBs generated at chromosomal loci (27).
We recently analyzed ATM function during recombination
of chromosomal substrates in v-abl–transformed mouse pre–B
cell lines (AMuLV pre–B cells) that can be induced to undergo
V(D)J recombination (28). Inhibition of the v-abl kinase
with STI571 leads to G1 cell-cycle arrest, rapid induction
of RAG gene expression, and, in wild-type AMuLV pre–B
cells, robust rearrangement of chromosomally integrated retroviral recombination substrates (28). In contrast, although
signal joint formation proceeds normally in ATM-deficient
AMuLV pre–B cells, unrepaired CEs accumulate in these
cells because of their loss from postcleavage complexes (28).
Furthermore, these CEs are frequently aberrantly resolved as
translocations or large chromosomal deletions or inversions (28).
These results demonstrate that, in AMuLV pre–B cells, ATM
performs an important, nonredundant function during coding joint formation.
Antigen receptor gene assembly at all loci in developing
B and T cells relies on efficient coding joint formation, yet
the T lymphopenia of ATM deficiency is much more profound than the B lymphopenia (12, 15). In addition, in
developing ATM-deficient T cells, the most dramatic block
in development is at the stage where TCRα chain genes are
assembled and expressed (12). Finally, the antigen receptor gene
translocations found in malignant and nonmalignant T cells
from ATM-deficient mice primarily involve the TCRα/δ
locus (18). Thus, whether ATM deficiency leads to broad
defects in coding joint formation at all antigen receptor loci in
vivo, as well as how these defects contribute to the lymphoid
phenotypes of A-T, is not clear.
In this paper, using ligation-mediated PCR (LMPCR)
and Southern blot approaches, we show that unrepaired CEs,
but not SEs, accumulate at higher levels during the assembly
of TCR and Ig genes in developing ATM-deficient T and
B lymphocytes, respectively. Furthermore, we show that in
1372

ATM-deficient αβ T cells, the frequency of translocations
and unrepaired DSBs involving the chromosome containing
the TCRα/δ locus is related to the number of TCRα rearrangements that can be made in developing ATM-deficient
thymocytes. These findings unequivocally demonstrate that
ATM deficiency leads to broad defects in V(D)J recombination during both TCR and Ig gene assembly in developing
B and T cells. Moreover, these results have important implications for the role of V(D)J recombination defects in the
lymphoid phenotypes of A-T.
RESULTS
Accumulation of unrepaired TCR chain gene CEs
in ATM-deficient thymocytes
Deficiencies in proteins required for normal coding or signal joint formation should result in an increased accumulation of unrepaired CEs or SEs, respectively, in developing
lymphocytes. In Atm−/− mice, the most profound block in
lymphocyte development is at the CD4+:CD8+ (double
positive [DP]) stage of thymocyte development, where TCRα
chain genes are assembled and expressed (12). To determine whether ATM functions during TCRα chain gene
coding and/or signal joint formation, wild-type (Atm+/+)
and Atm−/− DP thymocytes were purified by flow cytometric cell sorting, and genomic DNA from these cells was assayed for Jα56 CEs and SEs by LMPCR (Fig. 1, A and B).
To optimize for CE detection, genomic DNA was treated
with a DNA polymerase to blunt DNA ends before linker
ligation. Whereas the analyses of Atm+/+ and Atm−/− DP
thymocytes revealed nearly equivalent levels of Jα56 SEs,
considerably higher levels of Jα56 CEs were detected in
Atm−/− DP thymocytes (Fig. 1 B). Thus, in agreement
with our findings in AMuLV pre–B cells, ATM deficiency
leads to coding joint, but not signal joint, defects during
TCRα chain gene assembly, as indicated by the increased
accumulation of unrepaired Jα56 CEs in ATM-deficient
DP thymocytes.
To determine whether ATM deficiency leads to coding
joint defects at other TCR loci, we assayed for TCRβ and δ
SEs and CEs in Atm+/+ and Atm−/− thymocytes. TCRβ
and δ chain genes are assembled in CD4−:CD8− (double
negative [DN]) thymocytes that express CD25 (29). CD25+
DN thymocytes were purified from Atm+/+ and Atm−/−
mice by flow cytometric cell sorting, and genomic DNA
from these cells was assayed for Jβ1.1, Jβ1.2, and Jδ1 CEs
and SEs by LMPCR (Fig. 1, C–E). As both the TCRβ and
δ loci have D gene segments, these analyses will also detect
CEs generated by cleavage at DJβ1.1, DJβ1.2, and DJδ1
rearrangements (Fig. 1, C, D, F, and G).
Atm+/+ and Atm−/− CD25+ DN thymocytes had nearly
equivalent levels of Jδ1 SEs (Fig. 1 E).These cells also had near
equivalent levels of Jβ1.1, Jβ1.2, and 3′Dβ1 SEs (detected
by the LMPCR for Jβ1 CEs; Fig. 1, C–E). However, as was
observed for the TCRα locus, there were higher levels of
unrepaired Jβ1.1, Jβ1.2, and Jδ1 CEs in Atm−/− DN thymocytes as compared with Atm+/+ DN thymocytes (Fig. 1 E).
ATM FUNCTIONS DURING CODING JOINT FORMATION | Huang et al.
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Figure 1. Increased TCR gene CE accumulation in developing
ATM-deficient T cells. (A) Schematic of the Jα56 gene segment (closed
rectangles) and its flanking RS (open triangles). Schematics of the CE/SE
intermediates ligated to the ANC linker are shown. The approximate locations of oligonucleotides (arrows) used for LMPCR and probes (horizontal
lines) are indicated. (B) LMPCR of genomic DNA from wild-type (Atm+/+)
and Atm−/− DP thymocytes for Jα56 CEs and SEs, as described in Materials
and methods, using the primers and probes shown in A. Shown are
fivefold serial dilutions of linker-ligated samples, as well as the no-ligase
control (−). (C) Schematic of the TCRδ locus showing the Dδ1 and Dδ2
gene segments (open rectangles) and their flanking RSs (closed triangles),
and the Jδ1 gene segment (closed rectangles) and its RS (open triangles).
Schematics of different CE/SE intermediates ligated to the BW linker are
shown. The approximate locations of oligonucleotides (arrows) used for
LMPCR and probes (horizontal lines) are indicated. (D) Schematic of the

TCRβ locus showing the Dβ1 gene segment (open rectangle) and its
flanking RSs (closed triangles), the Jβ1.1 and Jβ1.2 gene segments (closed
rectangles) and their RSs (open triangles), and different CE/SE intermediates ligated to the BW linker. The approximate locations of oligonucleotides (arrows) used for LMPCR and probes (horizontal lines) are indicated.
(E) LMPCR of the CD25+ DN thymocyte DNA for Jδ1, Jβ1.1, Jβ1.2, and
Dβ1 SEs, and Jδ1, Jβ1.1, and Jβ1.2 CEs, as described in Materials and
methods, using the primers and probes shown in C and D. Shown
are fivefold serial dilutions of linker-ligated samples, as well as the
no-ligase control (−). The IL-2 gene PCR is also shown as a DNA loading
control. (F) Sequence analyses of Jβ1.1 CE LMPCR products. BW linker
and germline Dβ1 and Jβ1.1 sequences are shown in bold. (G) Sequence
analyses of Jδ1 CE LMPCR products. BW linker and germline Dδ1, Dδ2,
and Jδ1 sequences are shown in bold. Palindromic (P) and nontemplated
(N) nucleotide additions are indicated.

Sequence analyses revealed that the Jβ1.1 and Jδ1 LMPCR
products were heterogeneous, and several included Dβ
and Dδ gene segment nucleotides, respectively (Fig. 1, F
and G). Collectively, these data demonstrate that ATM
deficiency leads to broad defects in coding joint formation
during different steps (V to J, D to J, and V to DJ) of TCR
gene assembly at multiple loci (TCRα, β, and δ) in developing thymocytes.

Defects in coding joint formation in developing
ATM-deficient B cells
To determine whether ATM functions during coding and/or
signal joint formation at Ig loci in developing B cells, IgH and
IgLκ chain gene CEs and SEs were assayed by LMPCR of genomic DNA from Atm+/+ and Atm−/− bone marrow (Fig. 2).
As was observed for TCR gene rearrangement, analyses
of Atm+/+ and Atm−/− bone marrow revealed similar levels
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of JH1 SEs at the IgH locus and Jκ1 SEs at the IgLκ locus
(Fig. 2 C). However, considerably higher levels of JH1 and
Jκ1 CEs were detected in Atm−/− bone marrow (Fig. 2 C).
Sequence analyses demonstrated that the LMPCR products
were heterogeneous and were generated by linker ligation to
DJH1, JH1, and Jκ1 CEs (unpublished data). Collectively,
these data demonstrate that developing ATM-deficient B
cells also have defects in coding joint formation, as indicated
by an increased accumulation of unrepaired CEs during DH
to JH and VH to DJH rearrangements at the IgH locus and
Vκ to Jκ rearrangements at the IgLκ locus.
Quantitative assessment of CE accumulation
in ATM-deficient thymocytes
The LMPCR analyses demonstrate that unrepaired CEs exist
at higher levels in developing Atm−/− lymphocytes. However, this type of analysis cannot be used to determine the
fraction of alleles that have unrepaired CEs, which is needed
to assess the potential developmental impact of coding joint

Figure 2. Increased IgH and IgL𝛋 CE accumulation in developing
ATM-deficient B cells. (A) Schematic of the IgH locus showing a
DH (open rectangle) gene segment and its flanking RSs (closed triangles),
the JH1 gene segment (closed rectangles) and its RS (open triangles), CE/SE
intermediates ligated to the BW linker, and oligonucleotides used for
LMPCR. (B) Schematic of the Jκ1 gene segment (closed rectangles), CE/SE
intermediates ligated to the BW linker, and oligonucleotides used for
LMPCR. Schematics of CE/SE intermediates ligated to the BW linker are shown.
The approximate locations of oligonucleotides (arrows) used for LMPCR
and probes (horizontal lines) are indicated. (C) LMPCR for JH SE/CE and Jκ1
SE/CE in Atm+/+ and Atm−/− bone marrow DNA, as described in Materials
and methods, using the primers and probes shown in A and B. Shown are
fivefold serial dilutions of linker-ligated samples, as well as the no-ligase
control (−). The IL-2 gene PCR is also shown as a DNA loading control.
1374

defects in ATM-deficient mice. As most antigen receptor loci
contain many gene segments, it would be difficult to quantitatively assay the total accumulation of unrepaired CEs at a specific
locus. Accordingly, we generated Atm+/+ and Atm−/− mice that
were homozygous for the TCRαsJ allele (TCRαsJ/sJ:Atm+/+
and TCRαsJ/sJ:Atm−/− mice, respectively; Fig. 3 A) (30). The
wild-type TCRα locus (TCRα+) has 100 Vα and 61 Jα
gene segments, and all Vα to Jα rearrangements occur by deletion (31). The TCRαsJ allele is identical to the wild-type
TCRα locus except that the 61 Jα gene segments have been
replaced with 2 Jα gene segments (Jα61 and Jα56) through a
multistep gene-targeting approach (Fig. 3 A) (30). Thus, rearrangement of any of the 100 Vα gene segments on the
TCRαsJ allele must occur to 1 of the 2 closely linked (0.4 kb)
Jα gene segments.
Southern blot analyses of TCRα signal and coding joints
in TCRαsJ/sJ thymocytes should reveal heterogeneously sized
fragments, as any 1 of the 100 Vα gene segments can rearrange to either of the 2 Jα gene segments in each individual
cell. However, as all of these rearrangements will involve the
generation of a SE and CE at one of the two closely linked
Jα gene segments, we reasoned that these DNA ends may be
detected as discrete fragments by Southern blotting.
Southern blot analyses of TCRαsJ/sJ:Atm+/+ and TCRαsJ/sJ:
Atm−/− thymocyte DNA digested with two restriction enzymes and hybridized to probe 8 (P8; Fig. 3 B) upstream of
Jα61 revealed fragments of the expected size for germline
TCRαsJ alleles and many different-sized fragments generated
by heterogeneous signal joint formation (Fig. 3 C). Importantly, prominent fragments of the expected size for Jα61 SEs
were also observed at equal intensities in TCRαsJ/sJ:Atm+/+
and TCRαsJ/sJ:Atm−/− thymocyte DNA (Fig. 3 C). These
fragments were sensitive to exonuclease V digestion, further
demonstrating that they likely represent unrepaired SEs (Fig.
3, D and E). Notably, prominent fragments of the expected size
for Jα56 SEs were not detected (Fig. 3 C). This would be expected if, like the wild-type TCRα locus, rearrangement of
the TCRαsJ allele is ordered, with the more 5′ Jα gene segment (Jα61) being used before the 3′ Jα gene segment (Jα56)
(32–34). In this regard, P8 would not detect Jα56 SEs on
TCRαsJ alleles that had undergone a Vα to Jα61 rearrangement, which deletes the P8-hybridizing region from the chromosome (Fig. 3 B). LMPCR analyses, however, confirmed
that Jα56 SEs are present at nearly equivalent levels in TCRαsJ/sJ:
Atm+/+ and TCRαsJ/sJ:Atm−/− thymocytes (Fig. 3 F).
Jα56 and Jα61 CEs were assayed by Southern blot analysis using two different restriction enzymes and a probe (CαI;
Fig. 4 A) downstream of the Jα56 gene segment (Fig. 4 A).
In addition to fragments expected for heterogeneous VJα
coding joints and germline TCRαsJ alleles, these analyses revealed a novel fragment of expected size for unrepaired Jα56
CEs in TCRαsJ/sJ:Atm−/− thymocyte DNA (Fig. 4, A and B).
This fragment was not present in TCRαsJ/sJ:Atm+/+ thymocyte DNA (Fig. 4 B). Furthermore, hybridization with SJA
probe 6 (PS6; Fig. 4 A) to a region between the Jα56 and
Jα61 gene segments revealed a fragment of expected size for
ATM FUNCTIONS DURING CODING JOINT FORMATION | Huang et al.
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Figure 3. Equivalent TCR𝛂sJ locus SE accumulation in Atm+/+ and
Atm−/− thymocytes. (A) Schematics of the wild-type TCRα+ and TCRαsJ
loci. The Vα (open rectangles) and Jα (closed rectangles) gene segments
are shown, as is the TCRα constant region gene (Cα; gray rectangles). The
number in parenthesis indicates the number of Jα segments in the locus.
(B) Southern blot analysis strategy. The relative positions of the HincII (H)
and StuI (S) sites and P8 are shown. Fragment sizes generated by germline
TCRαsJ alleles and Jα56 and Jα61 SEs are indicated. The schematics are
not drawn to scale. (C) Southern blot analyses of total thymocyte DNA
and kidney DNA (K) digested with either StuI or HincII and hybridized to
P8. Hybridization to PR2 is shown as a DNA loading control. The fragment
corresponding to the germline TCRαsJ allele is indicated by the asterisk.

The fragments corresponding to the Jα61 SE are also indicated (arrows).
The molecular mass markers (in kb) are indicated. (D and E) Thymocyte
genomic DNA was digested in the absence (−) or in the presence of increasing concentrations of exonuclease V (ExoV) before digestions with
StuI and hybridization to P8 (D). The fragment corresponding to the
germline TCRαsJ allele is indicated by the asterisk. Retention of the Jα61
SE band (arrow) in exonuclease V–treated samples was quantified as described in Materials and methods (E). (F) LMPCR analysis of Jα56 and
Jα61 SEs, as described in the Materials and methods. Shown are fivefold
serial dilutions of linker-ligated samples, as well as the no-ligase control (−).
IL-2 gene PCR is also shown as a DNA loading control.

Jα61 CEs only in TCRαsJ/sJ:Atm−/− thymocytes (Fig. 4, A
and B). Quantification of these novel fragments, as described
in Materials and methods, revealed that 17% (8% Jα56 and
9% Jα61) of TCRαsJ alleles in TCRαsJ/sJ:Atm−/− thymocytes
have unrepaired CEs. LMPCR analyses confirmed the increased accumulation of Jα56 and Jα61 CEs in TCRαsJ/sJ:
Atm−/− thymocytes (Fig. 4 C).
Treatment of genomic DNA with exonuclease V led to a
40% loss in hybridization of the Jα56 CE fragment (Fig. 4, D

and E). Treatment of genomic DNA with mung bean nuclease,
which opens hairpin-sealed CEs, before exonucleaseV treatment
led to a nearly complete loss of hybridization (Fig. 4, F and G).
Thus, approximately half of the unrepaired CEs in ATM-deficient
thymocytes are hairpin sealed, raising the possibility that ATM
may have some function in the hairpin opening process. Collectively, these data demonstrate that a substantial fraction of
TCRαsJ/sJ:Atm−/− thymocytes have unrepaired Jα CEs that exist
in either hairpin-sealed or opened configurations.
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Figure 4. Increased TCR𝛂sJ locus CE accumulation in Atm−/− thymocytes. (A) Southern analysis strategy showing the relative positions of
the NsiI (N) and StuI (S) sites, PS6, and the CαI probe. Fragment sizes
generated by germline TCRαsJ alleles and Jα56 and Jα61 CEs are indicated. The schematics are not drawn to scale. (B) Southern blot analyses
of total thymocyte DNA and kidney DNA (K) digested with either NsiI or
HincII and hybridized to the CαI probe or PS6. Bands corresponding to
Jα61 and Jα56 CEs are indicated (arrows). The band corresponding to the
germline fragment is indicated by an asterisk. Hybridization of StuI and
NsiI digested DNA to PR2 is shown as a DNA loading control. The molecular mass markers (in kb) are indicated. (C) LMPCR analysis of Jα56 and
Jα61 CEs, as described in Materials and methods. Shown are fivefold serial dilutions of linker-ligated samples. IL-2 gene PCR is also shown as a
DNA loading control. (D and E) Exonuclease V sensitivity of Jα56 CEs was

assayed by hybridizing the membrane from Fig. 3D to the CαI probe.
Bands corresponding to the Jα61 and Jα56 CEs are indicated (arrows).
The band corresponding to the germline TCRαsJ allele is indicated
by an asterisk. The positions of the molecular mass markers (in kb) are
indicated (D). Retention of the Jα56 CE band in exonuclease V–treated
samples was quantified as described in Materials and methods (E).
(F and G) TCRαsJ/sJ:Atm−/− thymocyte DNA was treated with mung bean
nuclease followed by exonuclease V before digestion with StuI and
hybridization to the CαI probe, as described in Materials and methods.
Fragments corresponding to Jα61 and Jα56 CEs are indicated (arrows).
The fragment corresponding to the germline TCRαsJ allele is indicated by an
asterisk (F). Retention of the Jα56 CE band in samples treated with mung
bean nuclease and exonuclease V was quantified as described in Materials
and methods (G).

Reduced chromosome 14 breaks and translocations
in TCR𝛂sJ/sJ:Atm−/− 𝛂𝛃 T cells
ATM-deficient mice have increased numbers of nonmalignant αβ T cells with karyotypic abnormalities involving
chromosome 14, which contains the TCRα/δ locus (11, 18).
Our analyses of V(D)J recombination in Atm−/− AMuLV pre–B
cells demonstrated that unrepaired CEs are frequently resolved
aberrantly as translocations or large chromosomal deletions or

inversions (28). In DP thymocytes, each TCRα allele usually
undergoes several Vα to Jα rearrangements (see Discussion).
Thus, the increased frequency of chromosome 14 aberrations
observed in Atm−/− αβ T cells could be due, in part, to the cumulative risk that any one of these multiple rearrangements
would be aberrantly resolved.
To investigate this possibility, cytogenetic analyses were performed on metaphases from proliferating TCRα+/+:Atm−/−
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and TCRαsJ/sJ:Atm−/− αβ T cells, as described in Materials
and methods. As discussed above, the TCRαsJ allele can undergo only two Vα to Jα rearrangements, whereas the wildtype TCRα allele has the potential to undergo many more
Vα to Jα rearrangements. Metaphases were hybridized with
red whole chromosome paint (WCP) for chromosome 14
and green WCP for chromosome 15, which serves as a control as it does not contain antigen receptor loci. Chromosome
14 or 15 aberrations were not observed in TCRα+/+:Atm+/+
or TCRαsJ/sJ:Atm+/+ αβ T cells (Fig. 5). In close agreement
with published studies, 8% of TCRα+/+:Atm−/− αβ T cells
had chromosome 14 aberrations (Fig. 5) (18). In contrast,
only 4% of TCRαsJ/sJ:Atm−/− αβ T cells had chromosome 14
aberrations (Fig. 5). Notably, the chromosome 14 aberrations
in TCRα+/+:Atm−/− and TCRαsJ/sJ:Atm−/− αβ T cells were
equally divided between translocations and replicated chromosomal breaks (Fig. 5 C). From these analyses, it is not possible to determine whether the observed chromosome 14
aberrations are derived from TCRα or TCRδ chain gene rearrangements. However, the TCRδ locus is unaltered on the
TCRαsJ allele, making it unlikely that the change in the frequency of chromosome 14 aberrations is caused by differences in the TCRδ locus–derived translocations. Collectively,
these findings demonstrate that ATM-deficient mice with
TCRα alleles that undergo fewer Vα to Jα rearrangements
have fewer peripheral αβ T cells with chromosome 14 aberrations. In addition, they suggest that RAG-induced DSBs
generated in ATM-deficient thymocytes can persist unrepaired, as indicated by the chromosome 14 breaks in mature
ATM-deficient αβ T cells.
DISCUSSION
In this paper, we show that ATM deficiency leads to broad
defects in coding joint formation in vivo, as indicated by the
increased accumulation of unrepaired CEs at Ig and TCR loci
in developing ATM-deficient B and T lymphocytes. In contrast, unrepaired SEs were found at nearly equivalent levels
when comparing wild-type and ATM-deficient lymphocytes,
demonstrating that ATM does not perform an essential nonredundant function during signal joint formation.
The structure of most antigen receptor loci prohibits the
simple quantitative assessment of the fraction of loci with
unrepaired CEs or SEs. However, through Southern blot
analysis of ATM-deficient thymocytes with a modified
TCRα locus (TCRαsJ), we show that 17% of alleles have
unrepaired Jα CEs (Fig. 4 B). That 2% of peripheral TCRαsJ/sJ:
Atm−/− αβ T cells have chromosome 14 breaks suggests that
at least some Jα CEs generated in ATM-deficient DP thymocytes can persist unrepaired for the period of time it takes
these cells to be positively selected and released into the periphery (Fig. 5). These findings are in remarkable agreement
with analyses of ATM-deficient AMuLV pre–B cells, which
revealed that 10–20% of retroviral recombination substrates
develop persistent unrepaired CEs after induction of V(D)J
recombination (28). Several lines of evidence, including
interphase fluorescent in situ hybridization, revealed that
JEM VOL. 204, June 11, 2007

Figure 5. Decreased chromosome 14 breaks and aberrant rearrangements in TCR𝛂sJ/sJ:Atm−/− 𝛂𝛃T cells. Metaphase WCP analysis
of wild-type (TCRα+/+:Atm+/+), ATM-deficient (TCRα+/+:Atm−/−), TCRαsJ/sJ
(TCRαsJ/sJ:Atm+/+), and ATM-deficient TCRαsJ/sJ (TCRαsJ/sJ:Atm−/−) lymph
node αβ T cells. Metaphases were hybridized to red chromosome 14
(TCRα/δ) and green chromosome 15 (control) WCPs. (A) Metaphases from
TCRαsJ/sJ:Atm+/+ (panel 1), TCRαsJ/sJ:Atm−/− (panel 2), and TCRα+/+: Atm−/−
(panels 3 and 4) αβ T cells. Chromosome translocations (arrows) and
broken chromosomes (asterisk) are indicated. (B) Number of metaphases with chromosome 14 (red) or 15 (green) breaks or translocations.
(C) Percentage of TCRα+/+:Atm−/− and TCRαsJ/sJ:Atm−/− metaphases with
chromosome 14 breaks (red) or translocations (blue). Datasets are pooled
from two individual experiments.

unrepaired CEs accumulate in these cells due, at least in part,
to their loss from postcleavage complexes (28). Although it is
not possible to perform similar types of analyses on developing
lymphocytes, we suspect that the loss of CEs from postcleavage
complexes also contributes to the coding joint defect observed
in developing ATM-deficient lymphocytes in vivo.
Cytogenetic analyses revealed that 2% of proliferating
TCRαsJ/sJ:Atm−/− αβ T cells have chromosome 14 translocations, suggesting that some Jα CEs are aberrantly resolved
(Fig. 5). In agreement, cytogenetic analyses of ATM-deficient
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AMuLV pre–B cells that had undergone recombination revealed that 1.5% had chromosomal translocations involving
the retroviral recombination substrate CEs (28). However,
Southern blot analysis of clones revealed that 14% of the retroviral substrates had aberrantly resolved CEs (28). This difference (1.5% by cytogenetic and 14% by clonal analysis) is
caused by the inability of cytogenetic approaches to detect
many chromosomal deletions and inversions involving the retroviral substrate (28). By analogy, we would expect that the true
fraction of TCRαsJ/sJ:Atm−/− αβ T cells with aberrant TCRαsJ
allele rearrangements is likely greater than the 2% with translocations detected using cytogenetic approaches (Fig. 5).
Defects in coding joint formation were found at both Ig
and TCR loci and during D to J and V to DJ rearrangements
in developing B and T cells, yet the lymphopenia of ATM
deficiency is more profound in the T cell than the B cell
compartment (15). It is possible that distinct features of TCR
gene assembly contribute to the more pronounced T lymphopenia of ATM deficiency. The generation of translocations or
large chromosomal deletions or inversions involving an antigen
receptor locus would likely prevent subsequent rearrangements. Inactivation of a single allele in this manner would
require the cell to generate an in-frame rearrangement on the
alternate allele if it is to continue development, whereas inactivation of both alleles would preclude any further development. The developmental impact of such a defect should be
greatest for loci that must undergo multiple rearrangements,
as each additional rearrangement increases the possibility of
inactivating the allele. In this regard, it is notable that in
ATM-deficient mice the most profound block in T cell development occurs at the DP thymocyte stage, where TCRα
chain genes are being assembled and expressed (12).
Developing T cells must assemble TCRα chain genes that
are in frame and encode TCRα chains that form nonautoreactive αβ TCRs capable of positive selection. Most randomly
generated αβ TCRs are not capable of mediating positive
selection (35–37). The large Vα and Jα gene segment clusters
are positioned such that all Vα to Jα rearrangements occur
by deletion (31). Thus, VJα rearrangements that are not in
frame, or that are in frame but do not encode a TCRα chain
that forms a selectable αβ TCR, can be replaced through
rearrangement of an upstream Vα to a downstream Jα gene
segment on the same allele. In addition, TCRα chains
that form autoreactive αβ TCRs can, in some instances, be
similarly replaced, rescuing the cell from negative selection
(38–40). These revision rearrangements proceed in an orderly
fashion using progressively more 3′ Jα gene segments in the
locus (32, 33). That most developing DP thymocytes must
undergo multiple Vα to Jα rearrangements on each allele,
as they attempt to generate a selectable αβ TCR, is supported by the defect in positive selection observed in TCRαsJ/sJ
mice (30).
A recent modeling study predicted that, on average, each
TCRα allele undergoes five Vα to Jα rearrangements in developing thymocytes (41). In contrast, the TCRαsJ allele can
undergo only two Vα to Jα rearrangements. In this regard, it
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is notable that TCRα+/+:Atm−/− αβ T cells have twice as
many chromosome 14 breaks and translocations as compared
with TCRαsJ/sJ:Atm−/− αβ T cells (Fig. 5). Thus, there is a
close correlation between the frequency of chromosome 14
breaks and translocations in ATM-deficient αβ T cells and
the potential number of Vα to Jα rearrangements that these
cells can make during thymocyte development. Collectively,
these findings suggest that, in ATM-deficient cells, loci that
undergo multiple rearrangements have an increased probability of generating a persistent unrepaired DSB or of sustaining
an aberrant rearrangement, both of which should inactivate
the allele and prevent further rearrangements.
What is the developmental impact of TCRα locus inactivation in ATM-deficient thymocytes? Although it is not possible to answer this question with certainty, an estimate of the
potential developmental impact can be made. In ATM-deficient AMuLV pre–B cells, 14% of rearrangements lead to
CEs that are aberrantly resolved in ways (translocations, deletions, and inversions) that would inactivate an antigen receptor locus (28). If 14% of TCRα gene rearrangements are also
resolved aberrantly and an average of five Vα to Jα rearrangements occur on each TCRα allele, then on average
there would be a 53% (1 − 0.865) possibility that a single
TCRα allele would be inactivated in developing ATM-deficient DP thymocytes. Furthermore, approximately one third
(0.53 × 0.53 = 0.28) of ATM-deficient DP thymocytes
would be expected to inactivate both TCRα alleles, precluding further development of these cells.
In addition to unrepaired TCRα CEs, unrepaired TCRβ
chain gene CEs are also found in ATM-deficient thymocytes
(Fig. 1 E). Thus, defects in TCRβ chain gene assembly may
also contribute to the T lymphopenia of ATM deficiency.
However, the only constraint on TCRβ chain gene assembly
is that it must be in frame and encode a TCRβ chain that can
form a pre-TCR (42). As a result, it is possible that developing
thymocytes may undergo fewer TCRβ chain gene rearrangements than TCRα chain gene rearrangements. Moreover,
the developmental impact of defects in TCRβ chain gene assembly may be blunted by the cellular expansion that occurs
during the DN to DP transition (42). In contrast, positive selection is not accompanied by a substantial cellular expansion
that could compensate for defects in TCRα chain gene assembly
in ATM-deficient thymocytes.
Defects in coding joint formation during IgH and IgLκ
chain gene assembly were also found in developing ATMdeficient B cells (Fig. 2 C), yet B cell development is minimally compromised in ATM-deficient mice (15). Like
TCRβ chain gene assembly, IgH chain genes need only to
be in frame and encode an IgH chain that can form a pre–B
cell receptor (BCR) (43, 44). Furthermore, the pro– to pre–
B cell transition is accompanied by a cellular expansion that
could compensate for defects in IgH chain gene assembly (43,
44). IgL chain genes are assembled in pre–B cells, and they
must encode an IgL chain that forms a nonautoreactive BCR
(43, 44). As is the case for TCRα chain gene assembly, IgL
chain gene assembly is not followed by a substantial cellular
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expansion that could compensate for defects in this process
(43, 44). Like the TCRα locus, the structure of the IgLκ locus
permits VJκ rearrangements to be replaced with new VJκ rearrangements, on the same allele, as pre–B cells attempt to generate a nonautoreactive BCR (45). However, unlike the αβ
TCR, there is no requirement for positive selection of the
BCR. Thus, the additional constraint of positive selection
may mandate more TCRα chain gene rearrangements in DP
thymocytes than IgL chain gene rearrangements in pre–B cells
and, as such, contribute to the more profound T cell lymphopenia of ATM deficiency.
It is also possible that developing T cells may have unique
requirements for ATM function in addition to its role in antigen receptor gene assembly. For example, recent studies in
macrophages have demonstrated that ATM deficiency leads
to constitutive c-Jun N-terminal kinase (JNK) activation
(46). JNK signals are involved in negative selection; therefore, if JNK activity is also perturbed in ATM-deficient thymocytes, this may contribute to the T lymphopenia of ATM
deficiency (47). In addition, like ATM-deficient mice, mice
that are deficient in both ATM and RAG eventually succumb
to thymic lymphomas (21). However, these lymphomas do
not have translocations involving the TCRα/δ locus (21). This
demonstrates that ATM deficiency can promote thymocyte
transformation through defects in processes other than the assembly of antigen receptor genes. Therefore, although we
demonstrate unequivocally that ATM-deficient lymphocytes
have defects in V(D)J recombination, the relative contribution
of these and other defects to the lymphoid phenotypes of A-T
remains to be determined.
MATERIALS AND METHODS
Mice. All mice were bred and maintained under specific pathogen-free conditions at the Washington University School of Medicine and were handled
in accordance with the guidelines set forth by the Division of Comparative
Medicine of Washington University.
Southern blot analyses. Southern blot analyses of genomic DNA and
PCR products were performed as previously described (30, 48). P8, the CαI
probe, and the RAG-2 probe (PR2) have been previously described (49).
PS6 is a 0.4-kb PCR fragment amplified from TCRαsJ/sJ genomic DNA using the PS6-1 and PS6-2 oligonucleotides (Table S1, available at http://
www.jem.org/cgi/content/full/jem.20061460/DC1). For exonuclease V
digestion, 15 μg of thymocyte DNA was treated with increasing concentrations of exonuclease V, using the manufacturer’s buffer conditions (USB
Corporation), for 1 h at 37°C before restriction enzyme digestion and
Southern blot analyses. For mung bean nuclease assays, 15 μg of thymocyte
DNA was digested with 12.5 U of mung bean nuclease (New England
Biolabs, Inc.) in 200 μl using the manufacturer’s buffer supplemented with
0.4 mM ZnSO4 at 25°C for 1 h before treatment with exonuclease V, as described in this section.
Quantification of Southern blot fragments. Quantifications of Southern blot fragments were performed on a PhosphorImager (Storm 840; GE
Healthcare) using ImageQuant software (GE Healthcare). The percentage of
TCRαsJ alleles with unrepaired Jα56 CEs was calculated from the Southern
blot of StuI-digested DNA probed with the CαI probe (Fig. 4 B) or PR2 as
a DNA loading control (Fig. 4 B).
The following formula was used to determine the percentage of TCRαsJ
allele Jα56 CEs:
JEM VOL. 204, June 11, 2007

J a56CE Thy R 2Thy
´ 100
C aI Kid R 2Kid
The hybridization intensity of the CαI probe hybridizing the Jα56 CE
fragment (Jα56CEThy) and PR2 hybridizing the RAG-2 gene fragment
(R2Thy) from TCRαsJ/sJ:Atm−/− thymus DNA is used. In addition, the hybridization intensity of the CαI probe hybridizing the germline TCRαsJ
allele fragment (CαIKid) and PR2 hybridizing the RAG-2 gene fragment
(R2Kid) from TCRαsJ/sJ:Atm−/− kidney DNA is used.
The percentage of TCRαsJ alleles with unrepaired Jα61 CEs was similarly calculated from Southern blotting of StuI-digested DNA probed with
PS6 (Fig. 4 B) using the following formula:
J a61CE Thy R 2Thy
´ 100
PS 6Kid R 2Kid
The hybridization intensity of PS6 hybridizing the Jα61 CE fragment
(Jα61CEThy) from TCRαsJ/sJ:Atm−/− thymus DNA and the hybridization
intensity of PS6 hybridizing the germline TCRαsJ allele fragment (PS6Kid)
from TCRαsJ/sJ:Atm−/− kidney DNA are used. R2Thy and R2Kid are as described in this section.
The flowing formulas were used for quantifying the retention of Jα61
SEs and Jα56 CEs, respectively, after exonuclease V or mung bean nuclease
and exonuclease V treatment:
J a61SE + ExoV GL+ ExoV
´ 100
J a61SE - ExoV GL- ExoV
and
J a56CE + ExoV GL+ ExoV
´ 100
J a56CE - ExoV GL- ExoV
The intensities of the Jα56 CE (Jα56CE), Jα61 SE (Jα61SE), or TCRαsJ
germline fragments in lanes that were either not treated (−ExoV) or treated
with different concentrations of exonuclease V (+ ExoV) are used (Fig. 3 D;
and Fig. 4, D and F).
LMPCR. LMPCR was performed as previously described (48). In brief,
4 μg of thymus DNA that was treated with the Klenow DNA polymerase
(New England Biolabs, Inc.) in the presence of dNTP before ligation to the
BW or ANC linker (48, 50). Heminested PCR was performed with Taq
polymerase (Roche Molecular Systems, Inc.), according to the manufacturer’s recommendation, using 1 mM MgCl2. All primary PCRs were performed at 94°C for 5 min, followed by 17 cycles of 94°C for 30 s, 57°C for
30 s, and 72°C for 60 s. This was followed by a final incubation at 72°C for
7 min. All secondary PCRs were performed at 94°C for 5 min, followed by
23–36 cycles (Table S1) at 94°C for 30 s, 58°C for 30 s, and 72°C for 60 s.
This was followed by a final incubation at 72°C for 7 min. Primer sequences
are provided in Table S1. Oligonucleotides used as probes for PCR products
are also listed in Table S1. IL-2 control PCR was performed as previously
described (32).
Flow cytometric cell sorting. To purify CD25+ DN thymocytes, total thymocytes were depleted with CD4- or CD8-expressing cells using magnetic
beads, according to the manufacturer’s instruction (Dynal), followed by flow
cytometric purification of CD25+ DN thymocytes (FACSDiva; Beckton
Dickinson) using PE-Cy7–conjugated anti-CD25 (BD Biosciences). The resulting cells were >95% CD25+ DN thymocytes. DP thymocytes were purified to >95% purity by flow cytometric cell sorting using FITC-conjugated
anti-CD8 and PE-Cy7–conjugated anti-CD4 (BD Biosciences).
Metaphase WCP analysis. Metaphases were prepared from ConA-stimulated peripheral T cells, as previously described (28). Fluorescent in situ hybridization of metaphase chromosomes using the mouse WCPs (Applied
Spectral Imaging) for chromosomes 14 (red) and 15 (green) were performed
using the manufacturer’s recommended procedure. In brief, denatured
probes were allowed to reanneal at 37°C for 20 min and were hybridized to
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denatured chromosomes for 16 h in a humidified chamber at 37°C. Stringency washing was done in 0.4× SSC at 70°C for 4 min, followed by 4×
SSC/0.1% Tween 20. DAPI-counterstained slides were mounted in antiquench mount (Vectashield; Vector Laboratories) and analyzed on an epifluorescence microscope (Axioplan 2ie; Carl Zeiss MicroImaging, Inc.). Image
acquisition and processing was done using ISIS software (Metasystems).
Online supplemental material. Table S1 presents a list of oligonucleotides
used for LMPCR and probes. For each SE or CE LMPCR, the allele-specific oligonucleotides used as PCR primers or Southern probes are grouped
with their names and sequences indicated. For TCRα locus LMPCR,
the primers used for detecting SEs and CEs in the wild-type TCRα locus
(TCRα+) or TCRαsJ locus (TCRαsJ) are grouped, respectively. The cycle
numbers for the primary and secondary reactions of the heminested PCR are
also indicated alongside the allele-specific primers that were used. Primers A,
B, and C are linker-specific primers. PS6-1 and PS6-2 are used to amplify
PS6 for thymocyte DNA Southern analyses. Online supplemental material is
available at http://www.jem.org/cgi/content/full/jem.20061460/DC1.
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